Matching articles for "scopolamine"
Issue 1757 · June 22, 2026
Tradipitant (Nereus) for Motion Sickness

The FDA has approved the oral substance P/neurokinin-1 (NK-1) receptor antagonist tradipitant ( Nereus – Vanda) for prevention of vomiting induced by motion in adults. Tradipitant is the first drug to be…

Med Lett Drugs Ther. 2026 Jun 22; 68(1757):97-8 doi:10.58347/tml.2026.1757a
The FDA has approved the oral substance P/neurokinin-1 (NK-1) receptor antagonist tradipitant ( Nereus – Vanda) for prevention of vomiting induced by motion in adults. Tradipitant is the first drug to be approved for motion sickness in more than 40 years. Other oral substance P/NK-1 receptor antagonists (i.e., aprepitant, rolapitant, and netupitant) have been available for years for prevention of chemotherapy-induced nausea and vomiting.
Issue 1757 · June 22, 2026 Free
Comparison Chart: Drugs for Motion Sickness (online only)

View the Comparison Chart: Drugs for Motion Sickness

Med Lett Drugs Ther. 2026 Jun 22; 68(1757):e98 doi:10.58347/tml.2026.1757g
View the Comparison Chart: Drugs for Motion Sickness
Issue 1735 · August 18, 2025 Free
In Brief: Hyperthermia with Scopolamine Patches

The FDA has required a new warning in the label for the scopolamine transdermal patch ( Transderm-Scōp , and generics) about a risk of serious or fatal hyperthermia. Scopolamine, an anticholinergic drug, is…

Med Lett Drugs Ther. 2025 Aug 18; 67(1735):136 doi:10.58347/tml.2025.1735g
The FDA has required a new warning in the label for the scopolamine transdermal patch ( Transderm-Scōp , and generics) about a risk of serious or fatal hyperthermia. Scopolamine, an anticholinergic drug, is FDA-approved for prevention of nausea and vomiting associated with motion sickness or recovery after surgery in adults; it is often used off-label to reduce drooling in children and adolescents with neurologic disorders.
Issue 1615 · January 11, 2021
Metoclopramide Nasal Spray (Gimoti) for Diabetic Gastroparesis

The FDA has approved Gimoti (Evoke), a nasal spray formulation of the dopamine-2 (D 2 ) receptor antagonist metoclopramide, for relief of symptoms in adults with acute and recurrent diabetic gastroparesis.…

Med Lett Drugs Ther. 2021 Jan 11; 63(1615):5-7
The FDA has approved Gimoti (Evoke), a nasal spray formulation of the dopamine-2 (D 2 ) receptor antagonist metoclopramide, for relief of symptoms in adults with acute and recurrent diabetic gastroparesis. Metoclopramide ( Reglan , and generics) has been available for years in conventional and orally-disintegrating tablets and in an injectable formulation. It is the only drug that is FDA-approved for treatment of diabetic gastroparesis.
Issue 1614 · December 28, 2020
IV Amisulpride (Barhemsys) for Postoperative Nausea and Vomiting

The FDA has approved IV amisulpride ( Barhemsys – Acacia), a selective dopamine-2 and -3 (D 2 /D 3 ) receptor antagonist, for prevention and treatment of postoperative nausea and vomiting (PONV) in adults.…

Med Lett Drugs Ther. 2020 Dec 28; 62(1614):205-8
The FDA has approved IV amisulpride ( Barhemsys – Acacia), a selective dopamine-2 and -3 (D 2 /D 3 ) receptor antagonist, for prevention and treatment of postoperative nausea and vomiting (PONV) in adults. It is the first antiemetic to be approved for rescue treatment of PONV in patients who have symptoms despite receiving antiemetic prophylaxis. Oral formulations of amisulpride are available in Europe for treatment of schizophrenia and acute psychotic episodes.
Issue 1582 · October 7, 2019
Advice for Travelers

Patients who receive pretravel advice can reduce their risk for many travel-related conditions. Vaccines recommended for travelers are reviewed in a separate issue.

Med Lett Drugs Ther. 2019 Oct 7; 61(1582):153-60
Patients who receive pretravel advice can reduce their risk for many travel-related conditions. Vaccines recommended for travelers are reviewed in a separate issue.
Issue 1582 · October 7, 2019
Expanded Table: Some Drugs for Altitude Illness, Jet Lag, and Motion Sickness (online only)

View the Expanded Table: Some Drugs for Altitude Illness, Jet Lag, and Motion Sickness

Med Lett Drugs Ther. 2019 Oct 7; 61(1582):e161-3
View the Expanded Table: Some Drugs for Altitude Illness, Jet Lag, and Motion Sickness
Issue 1466 · April 13, 2015
Advice for Travelers

Patients planning to travel to other countries often ask for information about prevention of diarrhea, malaria, and other travel-related conditions. Vaccines recommended for travelers based on their…

Med Lett Drugs Ther. 2015 Apr 13; 57(1466):52-8
Patients planning to travel to other countries often ask for information about prevention of diarrhea, malaria, and other travel-related conditions. Vaccines recommended for travelers based on their destination, length of stay, and planned activities were reviewed in a previous issue.
Issue 87 · November 1, 2009
Advice for Travelers

Patients planning to travel to other countries often ask physicians for information about appropriate vaccines and prevention of diarrhea and malaria. Guidelines are also available from the Infectious Diseases…

Treat Guidel Med Lett. 2009 Nov; 7(87):83-94
Patients planning to travel to other countries often ask physicians for information about appropriate vaccines and prevention of diarrhea and malaria. Guidelines are also available from the Infectious Diseases Society of America (IDSA).
Issue 45 · May 1, 2006
Advice for Travelers

Patients planning to travel to other countries often ask physicians for information about immunizations and prevention of diarrhea and malaria. More detailed advice for travelers is available from the Centers…

Treat Guidel Med Lett. 2006 May; 4(45):25-34
Patients planning to travel to other countries often ask physicians for information about immunizations and prevention of diarrhea and malaria. More detailed advice for travelers is available from the Centers for Disease Control and Prevention at 877-FYI-TRIP (877-394-8747) or www.cdc.gov/travel .
Issue 1134 · July 8, 2002
Drugs That May Cause Psychiatric Symptoms

Many drugs can cause psychiatric symptoms, but a causal connection is often difficult to establish. Psychiatric symptoms that emerge during drug treatment may also be due to the underlying illness, previously…

Med Lett Drugs Ther. 2002 Jul 8; 44(1134):59-62
Many drugs can cause psychiatric symptoms, but a causal connection is often difficult to establish. Psychiatric symptoms that emerge during drug treatment may also be due to the underlying illness, previously unrecognized psychopathology, or psychosocial factors. The withdrawal of some drugs can cause symptoms such as anxiety, psychosis, delirium, agitation or depression.